Carolina Tosin Bueno

Short Bio

Graduated in Degree of Pharmacy in the University of Mogi das Cruzes - Campus Villa Lobos, Sao Paulo (2013). Currently PhD student of the Faculty of Medicine, University of Sao Paulo, since 2014. Has experience in the area of pharmacogenetics applied to Hematology and Microbiology with emphasis in Molecular Biology.

Line of Investigation

  • Genética

Publications

  1. Vivona, D;LIMA, L. T.;RODRIGUES, A. C.;BUENO, C. T.;ALCANTARA, G. K.;BARROS, L. S.;HUNGRIA, V. T.;Chiattone,C.;CHAUFFAILLE, M. L.;Guerra-Shinohara, Elvira M.;.ABCB1 haplotypes are associated with P gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib. Oncology Letters,v.7,10.3892/ol.2014,2014;
  2. HORITA, MELANIE;BUENO, CAROLINA TOSIN;HORIMOTO, ANDREA R;LEMOS, PEDRO A;MORANDINI-FILHO, ANTONIO A;KRIEGER, JOSE E;SANTOS, PAULO C J L;PEREIRA, ALEXANDRE C;.MTRR rs326119 polymorphism is associated with plasma concentrations of homocysteine and cobalamin, but not with congenital heart disease or coronary atherosclerosis in Brazilian patients. IJC Heart & Vasculature,v.14,1 - 5,2017;
  3. MARCATTO, LEILIANE RODRIGUES;SACILOTTO, LUCIANA;BUENO, CAROLINA TOSIN;FACIN, MIRELLA;STRUNZ, CELIA MARIA CASSARO;DARRIEUX, FRANCISCO CARLOS COSTA;SCANAVACCA, MAURÍCIO IBRAHIM;KRIEGER, JOSE EDUARDO;PEREIRA, ALEXANDRE COSTA;SANTOS, PAULO CALEB JUNIOR LIMA;.Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial. BMC Cardiovascular Disorders (Online),v.16,PMC5112885,2016;
  4. LIMA, LUCIENE TEREZINA DE;BUENO, CAROLINA TOSIN;Vivona, Douglas;HIRATA, ROSARIO DOMIGUEZ CRESPO;HIRATA, MARIO HIROYUKI;HUNGRIA, VANIA TIESTSCHE DE MORAES;CHIATTONE, CARLOS SÉRGIO;ZANICHELLI, MARIA APARECIDA;CHAUFFAILLE, MARIA DE LOURDES LOPES FERRARI;GUERRA-SHINOHARA, ELVIRA MARIA;.Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients. Hematology (Luxembourg. Print),v.1,140724035945000,2014;
  5. SANTOS, PAULO CJL;BUENO, CAROLINA T;LEMOS, PEDRO A;KRIEGER, JOSÉ E;PEREIRA, ALEXANDRE C;.LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography. Lipids in Health and Disease,v.13,74,2014;
  6. LIMA, L. T.;Vivona, D;BUENO, C. T.;Hirata,R.D.C.;HIRATA, M. H.;LUCHESSI, A. D.;CASTRO, F. A.;CHAUFFAILLE, M. L.;Zanichelli,M.A;Chiattone, Carlos S.;HUNGRIA, V. T.;Guerra-Shinohara, Elvira M.;.Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology (Northwood),v.31,10.1007/s12032-,2014;
  7. GUERRA-SHINOHARA, E. M.;BERTINATO, J. F.;TOSIN BUENO, C.;CORDEIRO DA SILVA, K.;BURLACCHINI DE CARVALHO, M. H.;PULCINELI VIEIRA FRANCISCO, R.;ZUGAIB, M.;CERDA, A.;MORELLI, V. M.;.Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss. Thrombosis and Haemostasis,v.108,693 - 700,2012;
  8. Vivona, Douglas;BUENO, C. T.;Lima, Luciene T.;Hirata, Rosario D.C.;Hirata, Mario H.;Luchessi, André D.;Zanichelli, Maria A.;Chiattone, Carlos S.;Guerra-Shinohara, Elvira M.;.ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Blood Cells, Molecules & Diseases (Print),v.48,132 - 136,2012;